Search Results 151-160 of 1927 for ☎아이템매니아인증 [광고문의 텔레:GTTVTT] 급전디비파는곳 ☎

1. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

   This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

2. Application Process - Vascular Surgery Advanced Aortic Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

   Application process for the Vascular Surgery Advanced Aortic Fellowship at Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.

3. Service Requests - Metabolomics Core - Mayo Clinic Research

   Metabolites are susceptible to a large number of "pre-analytic" sources of variability that should be addressed before samples are collected. The core staff has ...

4. Allogeneic Mesenchymal Stromal Cell Donor Bank - Mayo Clinic

   About this study. The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, or from healthy volunteers, ...

5. Excellence in Mentorship - Training and Education - Center for Clinical and Translational Science (CCaTS)

   Master's privileges in Mayo Clinic Graduate School of Biomedical Sciences; Mentored at least two CCaTS scholars who have completed the KL2, Ph.D. or master's ...

6. William M. Stone, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher William M. Stone, M.D., is a vascular surgeon with expertise in open and endovascular surgery.

7. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease - Mayo Clinic

   About this study. The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ...

8. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease - Mayo Clinic

   Patients in this study will be allowed treatment with stable doses of oral aminosalicylates, oral corticosteroids, immunosupressants and antibiotics for the ...

9. Mine Cicek, Ph.D. - Mayo Clinic Faculty Profiles

   Molecular cancer genetic epidemiologist Mine Cicek, Ph.D., leads the Mayo Clinic Biorepositories Program.

10. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

    About this study. This will be a single-center, randomized, parallel group, multiple dose administration, double-blind, placebo-controlled study to evaluate ...